Litcius/Paper detail

Tralokinumab does not impact vaccine-induced immune responses: Results from a 30-week, randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis

Joseph F. Merola, Jerry Bagel, Peter Almgren, Mads A. Røpke, Katja Wendicke Lophaven, Natacha Strange Vest, Parbeer Grewal

2021Journal of the American Academy of Dermatology44 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAtopic dermatitisPlaceboRandomized controlled trialDermatologyInternal medicineAlternative medicinePathologyDermatology and Skin DiseasesPsoriasis: Treatment and PathogenesisMast cells and histamine
Tralokinumab does not impact vaccine-induced immune responses: Results from a 30-week, randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis | Litcius